#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma Deafness Chronic lymphocytic leukaemia Infantile spasms Hyperchylomicronaemia Adult T-cell lymphoma/leukaemia refractory Waldenstrom's macroglobulinaemia Leiomyosarcoma recurrent Peripheral T-cell lymphoma unspecified Progressive supranuclear palsy Chronic hepatitis B Acute myeloid leukaemia recurrent Metastatic gastric cancer Kaposi's sarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Castleman’s disease – Diagnostics Pleomorphic leiomyosarcoma – Trials in Disease Skin angiosarcoma – Trials in Disease Lysosomal storage disorder – Treatment Sjogren’s syndrome – Treatment Adrenocortical carcinoma – Trials in Disease Marginal zone lymphoma refractory – Trials in Disease Paraneoplastic neurological syndrome – Trials in Disease Progressive multifocal leukoencephalopathy – Trials in Disease Gaucher’s disease type I – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ag-946 Phosphate Exemestane Ibrexafungerp Trospium Chloride Pasireotide Patritumab Deruxtecan Ro7790121 Docetaxel YOHIMBINE HYDROCHLORIDE Lolium Perenne Selpercatinib Flupentixol Decanoate Ciprofloxacin Hydrochloride Exagamglogene Autotemcel Erythromycin Alemtuzumab Aavanc80-3'Hotof Tinengotinib Jab-21822 [99MTC]PSMA I&S More therapies…

    Learn about Your Condition

    Ebola disease Osteogenesis imperfecta Astrocytoma malignant Femoral neck fracture Fallopian tube cancer stage IV Cerebral amyloid angiopathy Biotinidase deficiency Chondrosarcoma metastatic Inguinal hernia Acute hepatic failure Facial paresis Congenital myopathy Neuroendocrine tumour MELAS syndrome Oesophageal carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Sacituzumab Govitecan and Zimberelimab for Muscle-Invasive Bladder Cancer in Patients Unable to Take Cisplatin or Unwilling to Have Surgery

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Zimberelimab
    • Sacituzumab Govitecan
    Italy

  • Study of vitamin D3 (cholecalciferol) as additional treatment for elderly patients with pneumonia or sepsis due to infection

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    • Pneumonia
    • Sepsis
    Investigated Drugs:
    • Colecalciferol
    Italy

  • Study of Isoprenaline and Epinephrine Treatment for Patients with Out-of-Hospital Cardiac Arrest with Non-Shockable Rhythm

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Isoprenaline Hydrochloride
    • Sodium Chloride Ph. Eur.
    Denmark

  • Study of Actisoufre nasal spray containing sodium sulfide and saccharomyces extract for adults and children over 6 years with acute rhinitis, rhinopharyngitis, and rhinosinusitis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • SACCHAROMYCES CEREVISIAE TYPE D EXTRACT
    • SODIUM SULFIDE NONAHYDRATE
    Poland

  • Study of tocilizumab compared to placebo in patients with chronic chondrocalcinosis who did not respond to standard treatments

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chondrocalcinosis
    Investigated Drugs:
    • Sodium Chloride
    • Tocilizumab
    France

  • Study of serotonin system changes in early Parkinson’s disease using [11C]DASB and [11C]SB207145 PET imaging in people with SNCA gene mutations

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • (1-(11C)METHYLPIPERIDIN-4-YL)METHYL 5-AMINO-6-CHLORO-1,4-BENZODIOXINE-8-CARBOXYLATE
    • 3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE
    France
Previous Page
1 … 779 780 781 782 783 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!